Journal of Family Medicine and Primary Care, 2020 Background: Highly active antiretroviral therapy (HAART) has progressively improved the life expectancies in HIV positive children. These antiretroviral drugs could possibly have an influence on the oral health status.
G Shanmugavadivel +5 more
doaj +1 more source
Associated oral manifestations with HIV southeastern Brazilian patients on antiretroviral therapy
Brazilian Journal of Otorhinolaryngology, 2023 Objectives: This study aimed to assess the prevalence of oral lesions in patients living with HIV infection and their association with CD4 count, viral load, and antiretroviral therapy in patients with HIV.
Brisa Ketrine Lustosa de Souza +6 more
doaj +1 more source
Highly Active Antiretroviral Therapy (HAART) [PDF]
Journal of Ethiopian Medical Practice, 2015 Highly active antiretroviral therapy (HAART) is a treatment strategy for HIV (human immunodeficiency virus)-infected patients that consists of administering three or more different drugs, including nucleoside reverse transcriptase inhibitors, protease inhibitors, and non-nucleoside reverse transcriptase inhibitors.
Daniel Thomas Ginat +1 more
openaire +3 more sources
Analysis of multiply spliced transcripts in lymphoid tissue reservoirs of rhesus macaques infected with RT-SHIV during HAART. [PDF]
, 2014 Highly active antiretroviral therapy (HAART) can reduce levels of human immunodeficiency virus type 1 (HIV-1) to undetectable levels in infected individuals, but the virus is not eradicated.
Adamson, Lourdes +8 more
core +12 more sources
Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. [PDF]
, 2007 OBJECTIVE: Increasing access to highly active antiretroviral therapy to reach all those in need in developing countries (scale up) is slowly expanding to HIV-positive children, but documented experience remains limited. We aimed to describe the clinical,
Akao, K +9 more
core +2 more sources
Highly active antiretroviral therapy [PDF]
BMJ, 2004 The barriers to providing highly active antiretroviral therapy (HAART) in poor countries have until recently seemed insurmountable. The cited problems have ranged from weak health systems and poor infrastructure to inadequate numbers of health professionals. In reality, the main barrier has been the very high cost of antiretroviral drugs.
openaire +2 more sources
Drug resistance and viral tropism in HIV-1 subtype C-infected patients in KwaZulu-Natal, South Africa: implications for future treatment options [PDF]
, 2011 Article approval pendingDrug resistance poses a significant challenge for the successful application of highly active antiretroviral therapy (HAART) globally. Furthermore, emergence of HIV-1 isolates that preferentially use CXCR4 as a coreceptor for cell
Ashika Singh +48 more
core +2 more sources
Panhypopituitarism in HIV patient receiving antiretroviral therapy
Russian Open Medical Journal, 2021 The article is dedicated to a clinical case of the panhypopituitarism development in a patient with HIV infection receiving antiretroviral therapy. The number of HIV-infected patients worldwide has increased significantly over the past decades.
Tatyana B. Morgunova +5 more
doaj +1 more source
Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials. [PDF]
, 2009 BACKGROUND: Directly observed therapy has been recommended to improve adherence for patients with HIV infection who are on highly active antiretroviral therapy, but the benefit and cost-effectiveness of this approach has not been established conclusively.
Altice +41 more
core +3 more sources
Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection [PDF]
, 2005 Coinfection with hepatitis B virus (HBV) is a common occurrence in human immunodeficiency virus (HIV)–positive patients and an increasing cause of morbidity and mortality.
Bertoletti, A. +9 more
core +1 more source